The chronic obstructive pulmonary disease (COPD) treatment market encompasses a broad range of therapeutics including bronchodilators, corticosteroids, and combination therapies used for alleviating symptoms and slowing progression of COPD. Some of the commonly prescribed medications include inhaled corticosteroids, short-acting beta-2 agonists, long-acting beta-2 agonists, anticholinergics,...